Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs

Oncogene

Volumn 25, Issue 34, 2006, Pages 4768-4776

  Ohta, S ^a  

^a Graduate School of Medicine   (Japan)

Author keywords

Apoptosis; Codon; Cybrid; Mitochondrial disease; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GENE PRODUCT; MITOCHONDRIAL DNA;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CARCINOGENESIS; CELL NUCLEUS TRANSPLANTATION; CODON; CYBRID; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TOLERANCE; GENE MUTATION; GENE TARGETING; HUMAN; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL GENETICS; MITOCHONDRION; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL NUCLEUS; DNA, MITOCHONDRIAL; DRUG RESISTANCE, NEOPLASM; GENOME; HUMANS; MITOCHONDRIA; MUTATION; NEOPLASMS;

MUS MUSCULUS;

EID: 33746877057     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209602     Document Type: Review

References (67)

1. Amuthan G, Biswas G, Zyang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG. (2001). EMBO J 20: 1910-1920.
2. Attardi G, Schatz G. (1988). Annu Rev Cell Biol 4: 289-333.
3. Attardi G, Yoneda M, Chomyn A. (1995). Biochim Biophys Acta 1271: 241-248.
4. Bayona-Bafaluy MP, Manfredi G, Moraes CT. (2003). Nucl Acids Res 31: e98.
5. Biswas G, Guha M, Avadhani NG. (2005). Gene 354: 132-139.
6. Carew JS, Huang P. (2002). Mol Cancer 1: 9.
7. Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G. (1991). Mol Cell Biol 11: 2236-2244.
8. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrerojimenez P, Thilly WG. (2001). Nat Genet 28: 147-150.
9. Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM et al. (2004). Carcinogenesis 25: 1157-1163.
10. Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H et al. (2002). Cancer Res 62: 6674-6681.
11. D'Aurelio M, Gajewski CD, Lin MT, Mauck WM, Shao LZ, Lenaz G et al. (2004). Hum Mol Genet 13: 3171-3179.
12. Desjardins P, de Muys JM, Morais R. (1986). Somat Cell Mol Genet 12: 133-139.
13. DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC. (1985). Ann Neurol 17: 521-538.
14. Dunbar DR, Moonie PA, Jacobs HT, Holt IJ. (1995). Proc Natl Acad Sci USA 92: 6562-6566.
15. Evans AR, Limp-Foster M, Kelley MR. (2000). Mutat Res 461: 83-108.
16. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM et al. (2000). Science 287: 2017-2019.
17. Geromel V, Kadhom N, Cebalos-Picot I, Ouari O, Polidori A, Munnich A et al. (2001). Hum Mol Genet 10: 1221-1228.
18. Ghelli A, Zanna C, Porcelli AM, Schapira AH, Martinuzzi A, Carelli V et al. (2003). J Biol Chem 278: 4145-4150.
19. Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V et al. (2002). Ann Neurol 52: 534-542.
20. Hayashi J, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I. (1991a). Proc Natl Acad Sci USA 88: 10614-10618.
21. Hayashi J, Ohta S, Takai D, Miyabayashi S, Sakuta R, Goto Y et al. (1993). Biochem Biophys Res Commun 197: 1049-1055.
22. Hayashi J, Tanaka M, Sato W, Ozawa T, Yonekawa H, Kagawa Y et al. (1990). Biochem Biophys Res Commun 167: 216-221.
23. Hayashi J, Yonekawa H, Watanabe S, Nonaka I, Momoi M, Kagawa Y et al. (1991b). Somatic cell genetical approaches to mitochondrial diseases. In: Sato T, DiMauro S (eds). Progress in Neuro-pathology. Raven: New York, pp 93-102.
24. Hayashi JI, Takemitu M, Nonaka M. (1992). Somatic Cell Mol Genet 18: 123-129.
25. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. (1990). Am J Hum Genet 46: 428-433.
26. Inoue K, Ito S, Takai D, Soejima A, Shisa H, LePecq JB et al. (1997). J Biol Chem 272: 15510-15515.
27. Isidoro A, Martinez M, Fernandez PL, Ortega AD, Santamaria G, Chamorro M et al. (2004). Biochem J 378: 17-20.
28. King MP, Attardi G. (1989). Science 246: 500-503.
29. King MP, Koga Y, Davidson M, Schon EA. (1992). Mol Cell Biol 12: 480-490.
30. Klein TM, Fitzpatrick-McElligott S. (1993). Curr Opin Biotechnol 4: 583-590.
31. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE et al. (2005). Science 309: 481-484.
32. Lee SR, Kwon KS, Kim SR, Rhee SG. (1998). J Biol Chem 273: 15366-15372.
33. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. (1997). Trends Genet 13: 450-455.
34. Linnartz B, Anglmayer R, Zanssen S. (2004). Cancer Res 64: 1966-1971.
35. Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P et al. (2001). Cancer Res 61: 5998-6001.
36. Manfredi G, Fu J, Ojaimi J, Sadlock JE, Kwong JQ, Guy J et al. (2002). Nat Genet 30: 394-399.
37. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S et al. (2005). Nat Immunol 6: 587-592.
38. Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M. (2002). Am J Pathol 160: 1857-1865.
39. McCord JM. (2000). Am J Med 108: 652-659.
40. Michiels C, Minet E, Mottet D, Raes M. (2002). Free Radic Biol Med 33: 1231-1242.
41. Moraes CT, Dey R, Barrientos A. (2001). Methods Cell Biol 65: 397-412.
42. Morais R, Zinkewich-Peotti K, Parent M, Wang H, Babai F, Zollinger M. (1994). Cancer Res 54: 3889-3896.
43. Nakano K, Ohsawa I, Yamagata K, Nakayama T, Sasaki K, Tarashima M et al. (2003). Mitochondrion 3: 21-27.
44. Nakashima-Kamimura N, Asoh S, Ishibashi Y, Mukai Y, Shidara Y, Oda H et al. (2005). J Cell Sci 118: 5357-5367.
45. Nishikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T et al. (2001). Cancer Res 61: 1843-1845.
46. Ohta S. (2003). Curr Med Chem 10: 2485-2494.
47. Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M et al. (2001). Cancer Res 61: 7623-7626.
48. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J et al. (2005). Proc Natl Acad Sci USA 102: 719-724.
49. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD et al. (1998). Nat Genet 20: 291-293.
50. Qian W, Nishikawa M, Haque AM, Hirose M, Mashimo M, Sato E et al. (2005). Am J Physiol Cell Physiol 289: 1466-1475.
51. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G et al. (2005). Cancer Res 65: 1655-1663.
52. Shin YK, Yoo BC, Chang HJ, Jeon E, Hong SH, Jung MS et al. (2005). Cancer Res 65: 3162-3170.
53. Singh KK, Russell J, Sigara B, Zhang T, Williams J, Keshav KF. (1999). Oncogene 18: 6641-6646.
54. Takamatsu C, Umeda S, Ohsato T, Ohno T, Abe Y, Fukuoh A et al. (2002). EMBO J 3: 451-456.
55. Tan DJ, Bai RK, Wong LJ. (2002). Cancer Res 62: 972-976.
56. Tang JT, Yamazaki H, Inoue T, Koizumi M, Yoshida K, Ozeki S et al. (1999). Anticancer Res 19: 4959-4964.
57. Tatuch Y, Christodoulou J, Feigenbaum A, Clarke JT, Wherret J, Smith C et al. (1992). Am J Hum Genet 50: 852-858.
58. Trifunovic A, Hansson A, Wredenberg A, Rovio AT, Dufour E, Khvorostov I et al. (2005). Proc Natl Acad Sci USA 102: 17993-17998.
59. Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG. (2001). Proc Natl Acad Sci USA 98: 4038-4043.
60. Warburg O. (1930). The Metabolism of Tumors. Constable Co. Ltd.: London.
61. Warburg O. (1956). Science 123: 309-314.
62. Wong LJ, Lueth M, Li XN, Lau CC, Vogel H. (2003). Cancer Res 63: 3866-3871.
63. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN et al. (2005). Cancer Res 15: 613-621.
64. Yasukawa T, Yang MY, Jacobs HT, Holt IJ. (2005). Mol Cell 18: 651-662.
65. Yeh JJ, Lunetta KL, van Orsouw NJ, Moore Jr FD, Mutter GL, Vijg J et al. (2000). Oncogene 19: 2060-2066.
66. Yoneda M, Chomyn A, Martinuzzi A, Hurko O, Attardi G. (1992). Proc Natl Acad Sci USA 89: 11164-11168.
67. Yoneda M, Katsumata K, Hayakawa M, Tanaka M, Ozawa T. (1995). Biochem Biophys Res Commun 209: 723-729.